Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials | Zendy

Gustavo C. Román | Zendy; David Wilkinson | Zendy; Rachelle S. Doody | Zendy; Sandra E. Black | Zendy; Stephen Salloway | Zendy; Rachel Schindler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials

Author(s) -

Gustavo C. Román,

David Wilkinson,

Rachelle S. Doody,

Sandra E. Black,

Stephen Salloway,

Rachel Schindler

Publication year - 2005

Publication title -

dementia and geriatric cognitive disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.026

H-Index - 110

eISSN - 1421-9824

pISSN - 1420-8008

DOI - 10.1159/000088494

Subject(s) - donepezil , placebo , clinical dementia rating , dementia , vascular dementia , alzheimer's disease , medicine , randomization , psychology , randomized controlled trial , mini–mental state examination , disease , pathology , alternative medicine

There are currently no drugs approved to treat vascular dementia (VaD). The objective of this study was to determine if treatment with donepezil, an acetylcholinesterase inhibitor, may provide benefit for VaD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research